✦ LIBER ✦

A phase II study of 5-fluorouracil and high-dose folinic acid in combination with cyclophosphamide and mitoxantrone for advanced breast cancer

✍ Scribed by Aitini, Enrico; Cavazzini, Giovanna; Cantore, Maurizio; Rabbi, Carla; Rivera, Anna; Togliani, Beatrice; Marco, Adriano Di; Smerieri, Franco

Book ID: 122670865
Publisher: Elsevier Science
Year: 1992
Tongue: English
Weight: 395 KB
Volume: 28
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(92)90239-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Weekly 5-fluorouracil and high-dose foli

Weekly 5-fluorouracil and high-dose folinic acid in combination with epidoxorubicin as first-line therapy in advanced breast cancer: a phase II study

✍ Herbert Stöger, Thomas Bauerhofer… 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 415 KB

Mitoxantrone, folinic acid, 5-fluorourac

Mitoxantrone, folinic acid, 5-fluorouracil and prednisone as first-line chemotherapy for advanced breast carcinoma. A phase II study

✍ Carmo-Pereira, J.; Oliveira Costa, F.; Henriques, E. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 383 KB

Phase II study of high dose epirubicin i

Phase II study of high dose epirubicin in combination with cyclophosphamide in patients with advanced breast cancer

✍ Levi, J. A. ;Tattersall, M. H. ;Beith, J. M. ;Bell, D. ;Snyder, R. D. ;Wheeler, 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 449 KB

Randomized phase III Study of 5-fluorour

Randomized phase III Study of 5-fluorouracil plus high dose folinic acid versus 5-fluorouracil plus folinic acid plus methyl-lomustine for patients with advanced colorectal cancer

✍ Dennie V. Jones; Roger J. Winn; Barry W. Brown; Lawrence B. Levy; Reginald P. Pu 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 501 KB

Background. Metastatic colorectal cancer is generally incurable. The most active regimen available, 5-fluorouracil(5-FU) and folinic acid (Leucovorin), produces response rates of approximately 25% to 30%. Methyl-lomustine is a nitrosourea with modest activity against colorectal cancer. A randomized

Dose intensification of mitoxantrone in

Dose intensification of mitoxantrone in combination with paclitaxel in advanced breast cancer: a phase II study

✍ Francesco Di Costanzo; Andrea Sdrobolini; Luigi Manzione; Domenico Bilancia; Lui 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 42 KB

Cyclophosphamide, epirubicin, high-dose

Cyclophosphamide, epirubicin, high-dose folinic acid and 5-fluorouracil (super-FEC) as first-line chemotherapy for advanced breast cancer: Preliminary results

✍ Zaniboni, Alberto; Simoncini, Edda; Marpicati, Patrizia; Montini, Elisabetta; Fe 📂 Article 📅 1989 🏛 Elsevier Science ⚖ 553 KB